What are Mission Vision & Core Values of Edwards Lifesciences Company?

Edwards Lifesciences Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What Drives a Global Medtech Leader;

Mission and vision statements are crucial for any organization, defining its purpose and future aspirations. These declarations guide business decisions, unify corporate identity, and inspire stakeholders. A global medical technology leader exemplifies this, holding a significant position in structural heart disease and critical care.

Their innovations, especially in transcatheter aortic valve replacement (TAVR) and advanced hemodynamic monitoring, significantly improve patient quality of life and clinical outcomes. Their mission, vision, and values are vital in shaping their identity and driving strategic initiatives. For a deeper dive into the external factors influencing their operations, consider reviewing Edwards Lifesciences PESTEL Analysis.

The Edwards Lifesciences mission statement highlights its dedication to patients globally. It focuses on delivering innovative solutions for individuals battling cardiovascular disease, aiming to improve their quality of life. This commitment extends to fostering strong partnerships with customers, colleagues, and patients, creating a unified community focused on health outcomes.

Patient-Centric Focus

The core of Edwards Lifesciences' mission is its unwavering focus on people fighting cardiovascular disease, emphasizing patient well-being.

Innovative Solutions

The company is committed to developing and providing innovative solutions, such as advanced heart valve therapies and critical care monitoring technologies.

Global Impact

Edwards Lifesciences strives to improve the quality of life around the world, reflecting a broad, global market scope.

Trusted Partnerships

The mission emphasizes building trust with customers, colleagues, and patients, fostering a collaborative environment.

Continuous Discovery

A key aspect of their corporate philosophy is thriving on discovery and continually expanding boundaries to advance medical science.

Bold Action

The company acts boldly and decisively to achieve its mission, reflecting a proactive approach to healthcare challenges.

The Edwards Lifesciences mission is to provide innovative solutions for people fighting cardiovascular disease. This commitment drives their efforts to become trusted partners with customers, colleagues, and patients, fostering a community unified in its mission to improve global quality of life. Their results benefit all stakeholders: customers, patients, employees, and shareholders. The company celebrates successes, thrives on discovery, and continually expands its boundaries. They act boldly, decisively, and with determination on behalf of those affected by cardiovascular disease. This understanding of Edwards Lifesciences' company purpose is crucial for stakeholders, including the Owners & Shareholders of Edwards Lifesciences. For instance, the company's Transcatheter Aortic Valve Replacement (TAVR) sales reached $1.02 billion in Q4 2024, demonstrating the impact of their innovative solutions. Furthermore, their strategic investments in Transcatheter Mitral and Tricuspid Therapies (TMTT) saw sales surge by 88% in Q4 2024, showcasing their dedication to expanding life-changing innovations for patients with complex valve diseases, aligning with the Edwards Lifesciences vision for patient care.

Edwards Lifesciences SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Edwards Lifesciences' vision centers on transforming care for millions by addressing large, underserved opportunities in structural heart disease. This global ambition aims for expanded leadership in valvular and non-valvular structural heart diseases, embracing industry disruption through pioneering innovations. The company projects TAVR sales between $4.1 billion and $4.4 billion in 2025.

Edwards Lifesciences Mission

The Edwards Lifesciences mission is to innovate for structural heart disease, focusing on patient-centered solutions.

Edwards Lifesciences Vision

Edwards Lifesciences' vision is to lead global structural heart innovation, improving patient lives through advanced therapies.

Edwards Lifesciences Core Values

Edwards Lifesciences' core values emphasize patient focus, innovation, and a commitment to excellence.

Company Purpose

The company's purpose is deeply rooted in enhancing cardiovascular health and extending patient lives globally.

Organizational Values

Organizational values at Edwards Lifesciences guide ethical conduct, collaboration, and a drive for impactful medical solutions.

Corporate Philosophy

The corporate philosophy integrates scientific rigor with compassionate care, defining Edwards Lifesciences' approach to healthcare.

Edwards Lifesciences' vision is to be the leading global structural heart innovation company, driven by a passion to improve patient lives. This vision focuses on transforming care for millions by addressing large, underserved and growing opportunities in structural heart disease. The scope is global, aiming for expanded leadership in both valvular and non-valvular structural heart diseases, and embracing industry disruption through pioneering innovations. The company's ambition to achieve $2 billion in TMTT sales by 2030, alongside projections for its TAVR sales to be between $4.1 billion and $4.4 billion in 2025, demonstrates a realistic yet aspirational trajectory. This vision appears highly realistic given Edwards' dominant market position in TAVR, with a global market size reaching $6.2 billion in 2024 and projected to grow to nearly $10 billion by 2029, and its significant investments in a strong and differentiated pipeline of structural heart therapies. For more details on the company's background, read this Brief History of Edwards Lifesciences.

Edwards Lifesciences PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Edwards Lifesciences' core values are integral to its 'Credo', shaping its operations and interactions with a strong patient-focused culture. These values, while not explicitly listed as separate points, are foundational to the company's approach to innovation, collaboration, and stakeholder engagement.

The company's core values include a profound passion for helping patients, a relentless drive for discovery and expanding boundaries, fostering a community unified in its mission, and ensuring benefits for all stakeholders.

Passion to Help Patients

This is the paramount value, manifesting in every aspect from product development to strategic decisions. Edwards Lifesciences mission to improve lives is evident in its significant investment in research and development, committing over $1 billion in R&D in 2024 to create breakthrough technologies like the SAPIEN TAVR platform and new TMTT solutions.

Thrive on Discovery and Continually Expand Our Boundaries

This value drives innovation and continuous improvement, reflecting the vision behind Edwards Lifesciences innovation. It is evident in their robust pipeline of structural heart therapies and their willingness to act boldly, decisively, and with determination. For example, Edwards held 11 patents in artificial intelligence during Q1 2024, demonstrating their commitment to leveraging advanced technologies for patient monitoring and simplified medical procedures.

Community Unified in its Mission

This value highlights internal and external collaboration, fostering an environment where breakthrough ideas make a difference. With over 16,000 employees dedicated to helping patients, Edwards collaborates with leading clinicians and researchers globally and engages in philanthropic initiatives like 'Every Heartbeat Matters' (EHM), which by the end of 2025 aims to improve the lives of 2.5 million additional underserved structural heart and critical care patients, having already impacted over 2 million since 2020.

Benefit All Stakeholders (Customers, Patients, Employees, and Shareholders)

This emphasizes a balanced approach to value creation, aligning with Edwards Lifesciences corporate philosophy. The company's financial performance, with total organic sales growth of 9 percent in 2024 and projected 2025 sales growth of 8% to 10%, demonstrates value to shareholders while simultaneously investing in patient-focused innovations and employee engagement. Approximately 90% of Edwards employees engaged in charitable activities in 2024, impacting nearly 50 countries, showing a commitment to employees and communities.

These core values define Edwards Lifesciences and its commitment to patient care. To understand how these principles guide their market approach, explore the Target Market of Edwards Lifesciences. This will further illustrate how their mission and vision influence strategic decisions.

Edwards Lifesciences Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

A company's mission and vision are crucial in shaping its strategic direction, guiding decisions from product development to market expansion. These statements provide a clear purpose and a forward-looking aspiration that influences every aspect of the business.

Edwards Lifesciences: Mission, Vision, and Core Values

Edwards Lifesciences' strategic decisions are deeply rooted in its mission and vision, driving its focus on structural heart disease and patient-centric innovation.

• Mission: To improve the quality of life for patients fighting cardiovascular disease.
• Vision: To be the leading structural heart innovation company.
• Core Values: Emphasize patient focus, innovation, integrity, and teamwork.
• Strategic Alignment: The spin-off of the Critical Care unit at the end of 2024 exemplifies the company's sharpened focus on its core mission.

Strategic Influence of Mission and Vision

Edwards Lifesciences' mission and vision statements are the bedrock for its strategic decisions, leading to a concentrated focus on structural heart disease. This strategic direction is evident in its significant investments in areas like Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tricuspid Therapies (TMTT).

Investment in Innovation

The company's commitment to 'thrive on discovery' is demonstrated by its substantial R&D spending, which exceeded $1 billion in 2024, representing approximately 17-18% of its revenue. This investment fuels the development of breakthrough technologies aimed at improving patient outcomes.

Market Expansion and Growth

Edwards Lifesciences is aggressively expanding its presence in the TMTT market, with sales experiencing an 88% growth in Q4 2024 and projected to reach $2 billion by 2030. This growth is driven by innovative products and a vision to address significant unmet patient needs.

Measurable Success Metrics

In 2024, the company achieved a nine percent organic sales growth, with TAVR sales reaching $4.1 billion and TMTT sales at $378 million. These figures reflect the commercial success of their patient-focused innovations and strategic alignment.

Leadership Vision

CEO Bernard Zovighian's outlook for continued strong sales growth and the launch of breakthrough technologies underscores the direct link between strategic investment, innovation, and financial performance, aligning with the company's vision for the future of healthcare.

Impact on Operations and Culture

The company's mission and vision foster a patient-focused culture, inspiring employees to deliver life-changing innovations and guiding long-term planning to transform care and expand global reach, as further detailed in the Competitors Landscape of Edwards Lifesciences.

Edwards Lifesciences' mission and vision statements are instrumental in guiding its strategic decisions, from R&D investments to market expansion, ensuring a focused approach on improving patient lives in structural heart disease. Continue reading to explore core improvements to the company's mission and vision.

Edwards Lifesciences Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Enhancing the Edwards Lifesciences mission and vision involves refining their patient-centric focus for greater conciseness and incorporating forward-looking elements like technological innovation and sustainability. These adjustments aim to amplify their impact and ensure continued relevance in the evolving healthcare landscape.

Concise Mission Statement Integration

While the company's Credo is comprehensive, distilling its core purpose into a single, easily memorable sentence would align with industry best practices for immediate stakeholder understanding.

Emphasize Longevity in Vision Statement

Explicitly integrating the concept of enabling patients to live longer, healthier lives would better reflect the durable nature of their technologies and their impact on lifetime patient management.

Incorporate Digital Health and AI Commitment

Subtly weaving in their embrace of emerging technologies, such as the 11 AI patents filed in Q1 2024, would showcase their dedication to advanced patient care solutions.

Highlight Sustainability Initiatives

Reflecting their commitment to sustainability, like achieving carbon neutrality by 2030 and powering facilities with 39% renewable energy, would signal their forward-thinking approach to environmental responsibility.

The mission of Edwards Lifesciences is deeply rooted in improving patient outcomes, particularly in the realm of cardiovascular care. Understanding the Edwards Lifesciences company mission reveals a profound commitment to saving and improving lives through innovative medical technologies. This focus is central to the Edwards Lifesciences mission statement analysis, highlighting their dedication to advancing cardiac surgery and cardiovascular health. The company's purpose is to provide solutions that address critical unmet needs for patients suffering from debilitating heart conditions.

The Edwards Lifesciences vision for patient care is to be a global leader in transforming treatment for structural heart disease and other critical care conditions. This vision drives their innovation and shapes their strategic direction, as seen in their Growth Strategy of Edwards Lifesciences. Their vision for the future of healthcare involves creating technologies that offer superior clinical benefits and enhance the quality of life for patients worldwide. The vision behind Edwards Lifesciences innovation is to push the boundaries of medical science to deliver life-changing therapies.

The core values that define Edwards Lifesciences are centered around patient focus, innovation, integrity, and teamwork. These Edwards Lifesciences organizational values serve as the guiding principles for their operations and decision-making. The Edwards Lifesciences commitment to core values ensures that their actions consistently align with their overarching mission and vision. These guiding principles of Edwards Lifesciences foster a culture of excellence and ethical conduct throughout the organization.